MEDIMO
ActiveSummary
MEDIMO has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of -€194,605. Its solvency ranks better than 95% of 17,093 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Financials · financial year 2025, micro format
Turnover and EBIT margin not published: the micro format does not require them.
Peer companies
Historical observationOf the 132 companies that looked in July 2024 the way this one looks now, 3.0% went bankrupt within 24 months and 93.9% are still going.
- Small
- 2 to 5 years old
- solvency 30% or more
- a loss of 10% of the balance sheet or more
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 132 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2025 |
|---|---|
| Other operating charges640/8 | €23,753 |
| Gross operating margin9900 | -€60,783 |
| Operating profit (loss)9901 | -€84,536 |
| Financial income75/76B | €5,523 |
| Recurring financial income75 | €5,523 |
| Financial charges65/66B | €115,592 |
| Recurring financial charges65 | €115,592 |
| Profit (loss) for the period before taxes9903 | -€194,605 |
| Profit (loss) for the period9904 | -€194,605 |
| Profit (loss) for the period to be appropriated9905 | -€194,605 |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €1.9m | |
| Formation expenses20 | €0.003m | |
| Fixed assets21/28 | €1.8m | |
| Tangible fixed assets22/27 | €1.8m | |
| Land and buildings22 | €1.7m | |
| Assets under construction and advance payments27 | €0.1m | |
| Current assets29/58 | €0.1m | |
| Amounts receivable within one year40/41 | €0.002m | |
| Other amounts receivable41 | €0.002m | |
| Current investments50/53 | €0.09m | |
| Cash at bank and in hand54/58 | €0.01m | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €1.9m | |
| Equity10/15 | €1.9m | |
| Contributions10/11 | €2.1m | |
| Profit (loss) carried forward14 | -€0.2m | |
| Amounts payable17/49 | €0.004m | |
| Amounts payable within one year42/48 | €0.004m | |
| Trade debts44 | €0.004m | |
| Suppliers440/4 | €0.004m | |
| Other amounts payable47/48 | €320 | |
| Line | 2025 |
|---|---|
| Profit (loss) for the period9904 | -€194,605 |
| Operating cash flow (approximation) | -€194,605 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (1)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 30-07-2026 | 2026-00353264 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.